Related Experiment Video
Updated: Jan 28, 2026

Long-term High-Resolution Intravital Microscopy in the Lung with a Vacuum Stabilized Imaging Window
Published on: October 6, 2016
smartPearls® for dermal bioavailability enhancement - Long-term stabilization of suspensions by viscoelasticity
David Hespeler1, Daniel Knoth2, Cornelia M Keck2
1Freie Universität Berlin, Institute of Pharmacy, Germany.
Abstract:
smartPearls® are a novel dermal delivery system based on mesoporous (pores 2-50 nm) particles, developed in 2014. Their pores can be loaded with active which is long-term stabilized in its amorphous state. The increased saturation solubility by the amorphous state leads to an increased dermal bioavailability of poorly soluble actives. To avoid sedimentation of the porous particles (3-50 µm) in dermal formulations, viscoelastic gels were developed using ι-carrageenan, polyacrylate and the viscoelastic Kühne salad dressing as a reference from food industry. Silica particles (company Grace/US, 50 and 150 µm) were loaded into the gels and long-term stability was assessed by a VIS sedimentation test. Furthermore, the gels were characterized by analytical centrifugation (LUMiSizer®) to assess the critical rpm/g values, allowing to order them after their absolute viscoelastic stabilizing ability. Characterization was complemented by rotation rheology, amplitude sweep and a frequency sweep analysis for the determination of elastic and viscous moduli G' and G'' at varying conditions. Based on the throughout characterization, polymers can be selected to sufficiently stabilize dermal formulations even with large sized smartPearls® - the prerequisite for using this delivery system in dermal products.
More Related Videos
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
RNA Stability
Bioavailability Study Design: Absolute Versus Relative Bioavailability

